Retinoblastoma and uveal melanoma in Jordan: incidence, demographics, and survival (2011-2020)

References

• Dimaras H, Corson TW, Cobrinik D, White A, Zhao J, Munier FL, Abramson DH, Shields CL, Chantada GL, Njuguna F, et al. Retinoblastoma. Nat Rev Dis Primers. 1:15021. 2015 Aug 27.
   PubMedGoogle Scholar
• International Incidence of Childhood Cancer, Vol. II. IARC Sci Publ. 1998. 144:1–391.
   Google Scholar
• Jaradat I, Yousef YA, Mehyar M, Sultan I, Khurma S, Al-Rawashded K, Wilson M, Qaddoumi I, Salem A, Alnawaiseh I.Retinoblastoma in Jordan: an epidemiological study (2006-2010). Hematol Oncol Stem Cell Ther. 2011;4(3):126–31.
   PubMedGoogle Scholar
• Parkin DM, Krama´rova´ E, Draper GJ, Masuyer E, Michaelis J, Negia J, Qureschi S, Stiller CA. International incidence of childhood cancer, Vol II. IAR C Sci Publ. 1998;(2):1-391.
   Google Scholar
• Macklin MT. A study of retinoblastoma in Ohio. Am J Hum Genet. 1960 Mar;12(1):1–43.
   PubMed Web of Science ®Google Scholar
• Young JL, Smith MA, Roffers SD, Liff JM, Bunin GR. Retinoblastoma. In: Ries L, Smith M, Gurney G, editors. Cancer incidence and survival among children and adolescents: United States SEER program 1975-1995. NIH publication 395 no. 99-4649. Bethesda (MD): National Cancer Institute, SEER Program; 1999;1–182.
   Google Scholar
• Dimaras H, Kimani K, Dimba EA, Gronsdahl P, White A, Chan HS, Bl G. Retinoblastoma. Lancet. 2012;379;(9824):1436–46Epub 2012 Mar 12. doi:10.1016/S0140-6736(11)61137-9.
   PubMed Web of Science ®Google Scholar
• Kivelä T. 2009. The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. Br J Ophthalmol. 93(9):1129–31. doi:10.1136/bjo.2008.150292.
   PubMed Web of Science ®Google Scholar
• MacCarthy A, Draper GJ, Steliarova-Foucher E, Kingston JE. Retinoblastoma incidence and survival in European children (1978-1997). Report from the automated childhood cancer information system project. Eur J Cancer Oxf Engl 1990. 200642(13):2092–102. doi:10.1016/j.ejca.2006.06.003.
   Google Scholar
• Nyamori JM, Kimani K, Njuguna MW, Dimaras H. 2012. The incidence and distribution of retinoblastoma in Kenya. Br J Ophthalmol. 96(1):141–43. doi:10.1136/bjophthalmol2011-300739.
   PubMed Web of Science ®Google Scholar
• Leal-Leal C, Flores-Rojo M, Medina-Sansón A, Cerecedo-Díaz F, Sánchez-Félix S, González-Ramella O, Pérez-Pérez F, Gómez-Martínez R, Quero-Hernández A, Altamirano-Alvarez E, et al. A multicentre report from the Mexican retinoblastoma group. Br J Ophthalmol. 2004;88(8):1074–77.
   PubMed Web of Science ®Google Scholar
• Yousef YA, Al-Nawaiseh I, Mehyar M, Sultan I, Al-Hussaini M, Jaradat I, Mohammad M, AlJabari R, Abu-Yaghi N, Rodriguez-Galindo C, et al. How telemedicine and centralized care changed the natural history of retinoblastoma in a developing country: analysis of 478 patients. Ophthalmology. 2021;128(1):130–37. doi:10.1016/j.ophtha.2020.07.026.
   PubMed Web of Science ®Google Scholar
• Al-Nawaiseh I, Ghanem AQ, Yousef YA. Familial retinoblastoma: raised awareness improves early diagnosis and outcome.J Ophthalmol PMID: 28348883; PMCID: PMC5350530. 2017 [Epub 2017 Mar 2]; 2017:5053961. doi:10.1155/2017/5053961.
   PubMed Web of Science ®Google Scholar
• Yousef YA, AlNawaiseh T, AlJabari R, Muhsen S, Al-Nawaiseh I. Retinoblastoma awareness among first contact physicians in Jordan. Ophthalmic Genet. 2019;40(3):191–95.
   PubMed Web of Science ®Google Scholar
• Chan HSL, Thorner PS, Gb HG. Effect of chemotherapy on intraocular retinoblastoma. Int J Pediatr Hematol Oncol. 1995;2:269–81.
   Google Scholar
• Ancona-Lezama D, Dalvin LA, Shields CL.Modern treatment of retinoblastoma: a 2020 review. Indian J Ophthalmol. 2020;68(11):2356–65.
   PubMed Web of Science ®Google Scholar
• Shields CL, Honavar SG, Meadows AT, Shields JA, Demirci H, Singh A, Friedman DL, Naduvilath TJ.Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation. Am J Ophthalmol. 2002;133(5):657–64.
   PubMedGoogle Scholar
• Yousef YA, Noureldin AM, Sultan I, Deebajah R, Al-Hussaini M, Shawagfeh M, Mehyar M, Mohammad M, Jaradat I, AlNawaiseh I. Intravitreal melphalan chemotherapy for vitreous seeds in retinoblastoma. J Ophthalmol. 2020 Jan 24;2020:8628525.
   PubMedGoogle Scholar
• Hamel P, Heon E, Gallie BL, Budning AS.Focal therapy in the management of retinoblastoma: when to start and when to stop. J Aapos. 2000;4(6):334–37.
   PubMed Web of Science ®Google Scholar
• Abramson DH, Marr BP, Francis JH. Intra-Arterial chemotherapy for Retinoblastoma. JAMA Ophthalmol. 2016 Oct 1;134(10):1202.
   PubMedGoogle Scholar
• Yu GP, Hu DN, McCormick SA. 2006. Latitude and incidence of ocular melanoma. Photochem Photobiol. 82(6):1621–26. doi:10.1111/j.1751-1097.2006.tb09821.x.
   PubMed Web of Science ®Google Scholar
• Finger PT, Pavlick AC. Intraocular melanoma. In: Devita Jr VT, Lawrence TS, Rosenberg SA, editors. Devita, Hellman, and Rosenberg’s Cancer: principles & practice of oncology, 11th ed. Philadelphia: Wolters and Kluver; Chapter 11, 2019. pp. 1899–1909.
   Google Scholar
• American Brachytherapy Society - Ophthalmic Oncology Task Force. Electronic address: [email protected]; ABS – OOTF Committee. The American brachytherapy society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastoma. Brachytherapy. 2014;13(1):1–14.
   PubMedGoogle Scholar
• Gragoudas ES, Goitein M, Verhey L, Munzenreider J, Urie M, Suit H, Koehler A. Proton beam irradiation of uveal melanomas. Results of 5 1/2-year study. Arch Ophthalmol. 1982;100(6):928–34.
   PubMedGoogle Scholar
• Chiu-Tsao ST, Astrahan MA, Finger PT, Followill DS, Meigooni AS, Melhus CS, Mourtada F, Napolitano ME, Nath R, Rivard MJ, et al. Dosimetry of (125)I and (103)pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS. Med Phys. 2012;39(10):6161–84.
   PubMed Web of Science ®Google Scholar
• Finger PT. Radiation therapy for choroidal melanoma. Surv Ophthalmol. 1997;42(3):215–32.
   PubMed Web of Science ®Google Scholar
• Jaradat I, Zewar A, AlNawaiseh I, AlRawashdeh K, Khurma S, Mehyar M, Abdeen G, Yousef YA. Characteristics, management, and outcome of patients with uveal melanoma treated by Iodine-125 radioactive plaque therapy in a single tertiary cancer center in Jordan. Saudi J Ophthalmol. 2018;32(2):130–33.
   PubMedGoogle Scholar
• Zewar A, Nawaiseh I, Jaradat I, Khzouz J, Alrawashdeh K, Abdeen G, Mehyar M, Khurma S, Yousef YA. Management and outcome of uveal melanoma in a single tertiary cancer center in Jordan. Turk Patoloji Derg. 2016;32(3):186–92. English.
   PubMedGoogle Scholar
• Kujala E, Mäkitie T, Kivelä T. Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci. 2003;44(11):4651–59.
   PubMed Web of Science ®Google Scholar
• Diener-West M, Earle JD, Fine SL, Hawkins BS, Moy CS, Reynolds SM, Schachat AP, Straatsma BR, Collaborative Ocular Melanoma Study Group. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No 18. Arch Ophthalmol. 2001;119(7):969–82.
   PubMedGoogle Scholar
• Linn Murphree A. Intraocular retinoblastoma: the case for a new group classification. Ophthalmol Clin North Am. 2005;18:41–53.
   PubMedGoogle Scholar
• Mallipatna AC, Gallie BL, Chévez-Barrios P, Lumbroso-Le Rouic L, Chantada G, Doz F, Munier FL, et al. Retinoblastoma. In: Amin M, Edge S, Greene F, editors. AJCC Cancer Staging Manual. 8th ed. New York: Springer; 2017. pp. 819–31.
   Google Scholar
• Kivelä T, Simpson RE, Grossniklaus HE, et al. Uveal melanoma. AJCC Cancer Staging Manual. 8th. New York, NY:Springer;2016. pp. 805–17.
   Google Scholar
• Department of Statistics, Hashemite Kingdom of Jordan. Jordan in figures. 2020. In June 2021. http://dosweb.dos.gov.jo/DataBank/Population_Estimares/PopulationEstimates.pdf.
   Google Scholar
• Fernandes AG, Pollock BD, Rabito FA. Retinoblastoma in the United States: a 40-Year Incidence and Survival Analysis. J Pediatr Ophthalmol Strabismus. 2018;55(3):182–88.
   PubMedGoogle Scholar
• Bunin GR, Orjuela M, et al. Geographic and environmental factors. In: Singh A, Damato B, Pe’er J. editors Clinical ophthalmic oncology. Philadelphia: Saunders-Elsevier. 2007. pp.410–16.
   Google Scholar
• Broaddus E, Topham A, Singh AD. Incidence of retinoblastoma in the USA: 1975-2004. Br J Ophtthalmol. 2009;93(1):21–23.
   PubMed Web of Science ®Google Scholar
• Khandekar R, Ganesh A, Al Lawati J. A 12- year epidemiological review of retinoblastoma in Omani children. Ophthalmic Epidemiol. 2004;11(3):151–59.
   PubMed Web of Science ®Google Scholar
• Saw SM, Tan N, Lee SB, Au Eong KG, Chia KS. Incidence and survival characteristics of retinoblastoma in Singapore from 1968-1995. J Pediatr Ophthalmol Strabismus. 2000;37:87–93.
   PubMedGoogle Scholar
• Sanders BM, Draper GJ, Kingston JE. Retinoblastoma in Great Britain 1969–80: incidence, treatment, and survival. Br J Ophthalmol. 1988;72:576–83.
   PubMed Web of Science ®Google Scholar
• Pendergrass TW, Davis S. Incidence of retinoblastoma in the United States. Arch Ophthalmol. 1980;98:1204–10.
   PubMedGoogle Scholar
• Ozkan A, Pazarli H, Celkan T, Karaman S, Apak H, Kaner G, Uzel O, Yildiz I. Retinoblastoma in Turkey: survival and clinical characteristics 1981-2004. Pediatr Int. 2006;48(4):369–73.
   PubMedGoogle Scholar
• Ozdemir H, Tacyildiz N, Unal E, Yavuz G, Ugur H, Gunduz K. Clinical and epidemiological characteristics of retinoblastoma: correlation with prognosis in a Turkish pediatric oncology center. Pediatr Hematol Oncol. 2007;24(3):221–31.
   PubMed Web of Science ®Google Scholar
• Traboulsi EI, Jurdi-Nuwayhid F, Frangieh GT, Der Kaloustian VM. Retinoblastoma in Lebanon. Ophthalmic Paediatr Genet. 1986;7(1):29–34.
   PubMed Web of Science ®Google Scholar
• Al-Idrissi I, Al-Kaff AS, Senft SH. Cumulative incidence of retinoblastoma in Riyadh, Saudi Arabia. Ophthalmic Paediatr Genet. 1992;13(1):9–12.
   PubMed Web of Science ®Google Scholar
• Naseripour M, Nazari H, Bakhtiari P, Modarres-Zadeh M, Vosough P, Ausari M. Retinoblastoma in Iran: outcomes in terms of patients’ survival and globe survival. Br J Ophthalmol. 2009;93(1):28–32.
   PubMed Web of Science ®Google Scholar
• Sahu S, Banavali SD, Pai SK, Nair CN, Kurkure PA, Motwani SA, Advani SH. Retinoblastoma: problems and perspectives from India. Pediatr Hematol Oncol. 1998;15(6):501–08.
   PubMed Web of Science ®Google Scholar
• Mac Carthy A, Draper GJ, Steliarova-Foucher E, Kingston JE. Retinoblastoma incidence and survival in European children (1978-1997). Eur J Cancer. 2006;42(13):2092–102.
   PubMedGoogle Scholar
• Moll AC, Kuik DJ, Bouter LM, Den Otter W, Bezzemer PD, Koten JW, Imhof SM, Kuyt BP, Tan KE. Incidence and survival of retinoblastoma in the Netherlands: a register based study 1862–1995. Br J Ophthalmol. 1997;81:559–62.
   PubMed Web of Science ®Google Scholar
• Yousef YA, Tbakhi A, Al-Hussaini M, AlNawaiseh I, Saab A, Afifi A, Naji M, Mohammad M, Deebajah R, Jaradat I, et al. Mutational analysis of the RB1 gene and the inheritance patterns of retinoblastoma in Jordan. Fam Cancer. 2018;17(2):261–68. doi:10.1007/s10689-017-0027-5. PMID: 28803391.
   PubMed Web of Science ®Google Scholar
• Mallipatna A, Marino M, Singh AD. Genetics of Retinoblastoma. Asia Pac J Ophthalmol (Phila). 2016;5(4):260–64.
   PubMed Web of Science ®Google Scholar
• Mehyar M, Mosallam M, Tbakhi A, Saab A, Sultan I, Deebajah R, Jaradat I, AlJabari R, Mohammad M, AlNawaiseh I, et al. Impact of RB1 gene mutation type in retinoblastoma patients on clinical presentation and management outcome. Hematol Oncol Stem Cell Ther. 2020;13(3):152–59.
   PubMedGoogle Scholar
• Naseripour M. “Retinoblastoma survival disparity”: the expanding horizon in developing countries. Saudi J Ophthalmol. 2012;26(2):157–61 Epub 2012 Feb 18. doi:10.1016/j.sjopt.2012.02.003.
   PubMedGoogle Scholar
• Siegel RL, Miller KD, Fuchs HE, Jemal A. The American cancer society website cancer statistics, 2021. CA Cancer J Clin. 2021. 71(1):7–33. sources accessed February 2021. doi: 10.3322/caac.21654.
   PubMed Web of Science ®Google Scholar
• Canadian Cancer Statistics Advisory Committee. Canadian cancer statistics 2019. Toronto, ON: Canadian Cancer Society; 2019.
   Google Scholar
• MacCarthy A, Birch JM, Draper GJ, Hungerford JL, Kingston JE, Kroll ME, Stiller CA, Vincent TJ, Murphy MF. Retinoblastoma: treatment and survival in Great Britain 1963 to 2002. Br J Ophthalmol. 200993(1):38–39. Epub 2008 Oct 6. doi:10.1136/bjo.2008.139626. PMID: 18838414.
   PubMed Web of Science ®Google Scholar
• Chang CY, Chiou TJ, Hwang B, Bai LY, Hsu WM, Hsieh YL.Retinoblastoma in Taiwan: survival rate and prognostic factors. Jpn J Ophthalmol. 2006;50(3):242–49.
   PubMedGoogle Scholar
• Chawla B, Hasan F, Azad R, Seth R, Upadhyay AD, Pathy S, Pandey RM. Clinical presentation and survival of retinoblastoma in Indian children. Br J Ophthalmol. 2016;100(2):172–78.
   PubMed Web of Science ®Google Scholar
• Alsuhaibani AH. Uveal melanoma in the Saudi Arabian population: Two decades of management at the king khaled eye specialist hospital. Saudi J Ophthalmol. 2009;23(2):157–63 Epub 2009 Aug 5. doi:10.1016/j.sjopt.2009.05.003.
   PubMedGoogle Scholar
• Kuo PK, Puliafito CA, Wang KM, Liu HS, Wu BF. Uveal melanoma in China. Int Ophthalmol Clin. 1982;22(3):57–71. doi:10.1097/00004397-198202230-00007. PMID: 7107133.
   PubMedGoogle Scholar
• Collaborative Ocular Melanoma Study Group. 2001a. The Collaborative ocular melanoma study (COMS) randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings: COMS Report No. 18. Arch Ophthalmol. 119:969–82.
   PubMedGoogle Scholar
• Finger PT, Chin KJ, Duvall G. Palladium-103 for Choroidal Melanoma Study Group. Palladium-103 ophthalmic plaque radiation therapy for choroidal melanoma: 400 treated patients. Ophthalmology. 2009: 116(4): 790-6, 796.e1.
   PubMedGoogle Scholar
• Collaborative Ocular Melanoma Study Group. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28. Arch Ophthalmol. 2006;124(12):1684–93.
   PubMedGoogle Scholar
• Straatsma BR. The Jules François Memorial lecture. The collaborative ocular melanoma study and management of choroidal melanoma. Bull Soc Belge Ophtalmol. 2002;283:5–11. PMID: 12058487.
   Google Scholar
• Hawkins BS, Collaborative ocularOcular Melanoma Study Group. The Collaborative ocular melanoma study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma: IV. Ten-year mortality findings and prognostic factors. COMS report number 24. Am J Ophthalmol. 2004;138(6):936–51.
   PubMed Web of Science ®Google Scholar
• Shields CL, Kaliki S, Furuta M, Mashayekhi A, Shields JA. Clinical spectrum and prognosis of uveal melanoma based on age at presentation in 8,033 cases. Retina. 2012;32(7):1363–72. doi:10.1097/IAE.0b013e31824d09a8.
   PubMed Web of Science ®Google Scholar
• Nathan P, Hassel JC, Rutkowski P, Baurain JF, Butler MO, Schlaak M, Sullivan RJ, Ochsenreither S, Dummer R, Kirkwood JM, et al. Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma. N Engl J Med. 2021 Sep 23385(13): 1196–206. doi:10.1056/NEJMoa2103485. PMID: 34551229.
   PubMed Web of Science ®Google Scholar
• Collaborative Ocular Melanoma Study Group. Mortality in patients with small choroidal melanoma: COMS report no. 4. The collaborative ocular melanoma study group. Arch Ophthalmol. 1997a;115:886–93.
   PubMedGoogle Scholar
• Collaborative Ocular Melanoma Study Group. The collaborative ocular melanoma study (COMS) randomized trial of preenucleation radiation of large choroidal melanoma. II. Initial mortality findings. COMS Report No 10 Am J Ophthalmol. 1998b;125:779–96.
   PubMedGoogle Scholar
• Collaborative Ocular Melanoma Study Group. Screening for metastasis from choroidal melanoma: the collaborative ocular melanoma study group report no. 23. J Clin Oncol. 2004;22:2438–44.
   PubMedGoogle Scholar
• American Cancer Society’s (ACS) publication, Cancer Facts & Figures 2017 (January 2020); the ACS website (January 2020); the National Cancer Institute website (January 2020). Houle V, Bélair M, Allaire GSet al. AIRP Best Cases in Radiologic-Pathologic Correlation: Choroidal Melanoma. RadioGraphics. 2011:31(5):1231–36. January 2020. doi: 10.1148/rg.315105211.
   Google Scholar
• Collaborative Ocular Melanoma Study Group. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, II: characteristics of patients enrolled and not enrolled. COMS Report No. 17. Arch Ophthalmol. 2001b;119:951–65.
   Google Scholar